Third-party review, regulation of botanical therapeutic claims topics for March meeting.
This article was originally published in The Tan Sheet
Executive Summary
THIRD-PARTY REVIEW, REGULATION OF THERAPEUTIC CLAIMS FOR BOTANICAL PRODUCTS slated as topics of discussion for the Commission on Dietary Supplement Labels' March 4 meeting in Baltimore, Md. In Feb. 4 letters, commission Executive Director Kenneth Fisher, PhD, invited 13 trade, consumer, scientific and regulatory organizations -- including the Council for Responsible Nutrition, the National Nutritional Foods Association and the Nonprescription Drug Manufacturers Association -- to comment on the two issues at the meeting.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning